הידרולזות ליזוזומליות

Lysosomal hydrolases are acid hydrolases—enzymes that degrade macromolecules inside lysosomes. These enzymes are optimally active at an acidic pH between 4.5 and 5, where they use water molecules to break down chemical bonds in their substrates. They function in cellular processes including energy metabolism, cell signaling, and restoration of the plasma membrane.

Lysosomal hydrolases are produced in the rough endoplasmic reticulum and transported to the Golgi apparatus. In the Golgi, they are tagged with Mannose-6-Phosphate (M6P) groups added to N-linked oligosaccharides. Transmembrane receptors recognize M6P markers, anchoring the hydrolases on the membrane lumenal side while clathrin coats assemble on the cytosolic side, forming clathrin-coated vesicles that bud from the trans-Golgi network.

M6P receptors cannot bind hydrolases at pH lower than 6. When clathrin-coated vesicles reach the early endosome, its acidic pH prevents receptor-enzyme binding, causing the hydrolases to release into the endosomal lumen. The early endosome then matures to the late endosome and fuses with the lysosome, delivering enzymes to their final destination.

Lysosomal storage diseases result from genetic defects in lysosomal function, causing absence or deficiency of specific hydrolytic enzymes. Without functional enzymes, undigested molecules accumulate in the lysosome. This substrate accumulation causes organelle swelling and irreversible cellular damage. More than 40 such diseases are known, affecting approximately one in every 8,000 infants.

I-cell disease, or inclusion-cell disease, is a severe lysosomal storage disorder caused by a recessive single gene defect. Lysosomes lack most hydrolytic enzymes, leading to massive accumulation of undigested substrates. This creates large cellular inclusions that pathologically affect all organ systems, skeletal integrity, and mental development, making it one of the most severe forms of lysosomal storage disease.

Different lysosomal storage diseases result from deficiencies in specific enzymes. Tay-Sachs occurs when N-hexosaminidase, which degrades gangliosides, is deficient. Hurler's disease involves defective glycosaminoglycan breakdown enzymes. Pompe disease results from glucosidase absence, causing glycogen accumulation and fatal organelle swelling. Each enzyme deficiency produces distinct substrate accumulation patterns and disease symptoms.

Mannose-6-Phosphate (M6P) markers are recognition tags added to hydrolase oligosaccharides in the Golgi apparatus. Transmembrane receptors specifically recognize M6P groups, anchoring enzymes to the membrane and directing them into clathrin-coated vesicles. This M6P-receptor interaction ensures hydrolases are properly sorted and delivered to lysosomes through the endosomal pathway.